Il-Dong Pharmaceutical Launches Oral Hemorrhoid Drug 'Purepa Speed'

Available at Pharmacies Without Prescription · Enhanced Absorption for Faster Symptom Relief

Finance|
|
By Lee Yeon-su
||
null - Seoul Economic Daily Finance News from South Korea

Il-Dong Pharmaceutical announced on the 6th that it has launched "Purepa Speed Tablets," an oral hemorrhoid medication, to strengthen its lineup of hemorrhoid treatment brands.

The new product, Purepa Speed, is an over-the-counter drug containing micronized purified flavonoid fraction (MPFF). It is effective for hemorrhoids and venous lymphatic edema, including lower limb edema and pain. The drug can be purchased at pharmacies without a prescription.

The active ingredient MPFF is a complex substance that contains micronized diosmin along with active flavonoid components such as hesperidin, diosmetin, linarin, and isorhoifolin. According to Il-Dong Pharmaceutical, the diosmin used in Purepa Speed has been processed to an average particle size of less than 2µm to enhance absorption in the body. This design enables faster response to symptoms such as acute hemorrhoids.

Il-Dong Pharmaceutical's Purepa series of hemorrhoid treatments includes a diverse lineup of formulations beyond the newly launched Speed Tablets: △oral medication (Purepacen 600 Tablets), △topical treatments (Purepain Ointment and Purepain Mild Ointment), and △suppositories (Purepain Mild Suppositories). The company plans to market the new product while also promoting the benefits of combination therapy using various formulations and active ingredients.

"Hemorrhoids commonly present as mixed hemorrhoids involving both internal and external hemorrhoids, and symptoms such as pain, itching, and bleeding often occur in combination," a company official said. "It is effective to use oral medications, topical treatments, and suppositories together as appropriate, after consulting with a specialist."

Original reporting by Lee Yeon-su for Seoul Economic Daily.

AI-translated from Korean. Quotes from foreign sources are based on Korean-language reports and may not reflect exact original wording.

Watch · Seoul Economic Daily

More →
2:32

AI KEY

Preview
Korean Corporate Intelligence HubKOSPI · KOSDAQ · 12 sectors

A live, cap-weighted view of every KOSPI and KOSDAQ sector, with same-day Korean reporting distilled by company — built for foreign investors, correspondents and analysts who need to scan Korea before the next session.

Korea Company Atlas

Preview
Market Ontology · The Feedback LoopKFTC 2025 · 92 groups · 121,954 articles

An English ontology of the Korean market — how companies, the media, the government and the National Assembly move each other in a loop. Korea's named controlling persons and designated business groups are a mechanism, not a risk to be priced blind.

SIGNAL

Pre-register
English Edition · Capital MarketsM&A · IPO · PE · Fund Flows

Pre-register for SIGNAL English Edition — a premium subscription bringing Korean capital markets coverage (M&A, IPOs, private equity, fund flows) to global institutional investors. First access to the 50% introductory rate.